A09514 Summary:

BILL NOA09514A
 
SAME ASSAME AS S07249-A
 
SPONSORGottfried
 
COSPNSRDinowitz, Paulin, Hevesi, Lupardo, Blake, Zebrowski, Skartados, Russell, Ortiz, Simon, Brindisi, Cook, Sepulveda, Abinanti, Katz, McDonald, Seawright, Weprin
 
MLTSPNSRHyndman
 
Amd 3360, Pub Health L
 
Authorizes the use of medical marihuana for severe chronic pain not associated with another listed condition.
Go to top    

A09514 Actions:

BILL NOA09514A
 
03/10/2016referred to health
05/03/2016amend and recommit to health
05/03/2016print number 9514a
05/23/2016reported
05/26/2016advanced to third reading cal.822
Go to top

A09514 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A9514A
 
SPONSOR: Gottfried (MS)
  TITLE OF BILL: An act to amend the public health law, in relation to conditions permitting the use of medical marihuana   PURPOSE: To allow medical marihuana to be used to treat severe chronic pain   SUMMARY OF SPECIFIC PROVISIONS: Section 1: Amends subdivision 7 of § 3360 of the Public Health Law by adding "severe chronic pain" to the list of diseases and conditions treatable by use of medical marihuana. Section 2: Effective date.   JUSTIFICATION: The medical marihuana law authorizes use of medical marihuana for treat- ment of "severe or chronic pain" only when it is associated with another of certain conditions. This legislation authorizes it for severe chronic pain on its own. Severe chronic pain is often treated with opioids that are much more dangerous and addictive than medical marihuana. Research in the Journal of the American Medical Association suggests that authorizing medical marihuana for severe chronic pain treatment may reduce mortality from opioid abuse. http://mediajamanetwork. com/news-itern/lower- opioid- overdose- death- ratesassociated- with-state-medical- marijuana-laws/ Expanding the list of conditions to include severe chronic pain on its own would offer critical treatment options to more patients whose lives could be improved by medical marihuana.   PRIOR LEGISLATIVE HISTORY: New bill.   FISCAL IMPLICATIONS: None.   EFFECTIVE DATE: Immediately.
Go to top

A09514 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                         9514--A
 
                   IN ASSEMBLY
 
                                     March 10, 2016
                                       ___________
 
        Introduced  by  M.  of  A. GOTTFRIED, DINOWITZ, PAULIN, HEVESI, LUPARDO,
          BLAKE, ZEBROWSKI, SKARTADOS, RUSSELL, ORTIZ,  SIMON,  BRINDISI,  COOK,
          SEPULVEDA,  ABINANTI, KATZ, McDONALD -- Multi-Sponsored by -- M. of A.
          HYNDMAN -- read once and  referred  to  the  Committee  on  Health  --
          committee  discharged,  bill amended, ordered reprinted as amended and
          recommitted to said committee

        AN ACT to amend the public health law, in relation to conditions permit-
          ting the use of medical marihuana
 
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  Paragraph  (a)  of  subdivision  7 of section 3360 of the
     2  public health law, as added by chapter  90  of  the  laws  of  2014,  is
     3  amended to read as follows:
     4    (a) "Serious condition" means:
     5    (i)  having one of the following severe debilitating or life-threaten-
     6  ing conditions: cancer, positive status for human immunodeficiency virus
     7  or acquired immune deficiency syndrome, amyotrophic  lateral  sclerosis,
     8  Parkinson's disease, multiple sclerosis, damage to the nervous tissue of
     9  the  spinal  cord  with objective neurological indication of intractable
    10  spasticity,  epilepsy,   inflammatory   bowel   disease,   neuropathies,
    11  Huntington's  disease,  severe  chronic pain (in which other therapeutic
    12  interventions, including opiate therapy, are  contraindicated,  ineffec-
    13  tive,  or  likely to have more serious side effects), or as added by the
    14  commissioner; and
    15    (ii) any of the following conditions where it is clinically associated
    16  with, or a complication of, a condition  under  this  paragraph  or  its
    17  treatment:  cachexia or wasting syndrome; severe or chronic pain; severe
    18  nausea; seizures; severe or persistent muscle spasms; or such conditions
    19  as are added by the commissioner.
    20    § 2. This act shall take effect immediately; provided that the  amend-
    21  ments  to  title  5-A  of  article  33  of the public health law made by
    22  section one of this act shall not affect the expiration  and  repeal  of
    23  such title and shall expire and be deemed repealed therewith.

         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD13979-02-6
Go to top